ArriVent BioPharma
AVBP
AVBP
98 hedge funds and large institutions have $731M invested in ArriVent BioPharma in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 25 increasing their positions, 29 reducing their positions, and 9 closing their positions.
Holders
98
Holders Change
+15
Holders Change %
+18.07%
% of All Funds
1.32%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.08%
New
26
Increased
25
Reduced
29
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
BlackRock
New York
|
$40M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$1.89M |
3 |
OCA
3
Octagon Capital Advisors
New York
|
$42.4M |
4 |
4
Two Sigma Investments
New York
|
$0 |
5 |
5
Northern Trust
Chicago,
Illinois
|
$4.5M |